Função Pulmonar por Posição da Ninhada
A litter is often needed to extract a person from an austere environment like the wilderness or from confined, urban spaces. A horizontal litter is generally assumed to be better for patient care, but often makes for a more difficult, if not impossible, evacuation from some settings such as confined space rescue, cave rescue, or wilderness rescue when the litter must be moved up or down a cliff with an undercut edge. A litter in a vertical orientation is easier to move in these situations, which may expedite movement towards definitive care. In some wilderness rescue circles, the mantra is that movement IS definitive care. It is already known that lying flat on the ground negatively affects pulmonary function compared to a sitting baseline.1 It is possible that a vertically oriented litter is better for a subset of patients with respiratory issues than a horizontal litter. The investigators hypothesize that pulmonary function measured by FEV1, FVC, and FEV1/FVC, is better in simulated patients in a vertically oriented litter compared to a horizontally oriented one.
Visão geral do estudo
Status
Intervenção / Tratamento
Descrição detalhada
Objective To quantify changes in pulmonary function tests (PFTs) based on litter position.
Hypotheses:
- Compared to sitting baseline, all PFTs in the litter will have decreased forced vital capacity (FVC) and 1 second forced expiratory volume (FEV1).
- Compared to lying down, persons straight upright and pitched forward will have better forced vital capacity (FVC) and 1 second forced expiratory volume (FEV1).
- We do not hypothesize any changes in FEV1/FVC.
Study Design This randomized crossover study will use twelve healthy volunteers. All subjects will do baseline sitting pulmonary testing. Experimental order is balanced to avoid any training effects. Choice of sequence will be by random selection of envelope.
Methods Once consented, included subjects will do baseline sitting measurement of FEV1 and FVC which will give FEV1/FVC. Each subject will then be secured in a Ferno-Washington Model 71 litter wearing their own type 2 or 3 harness, or in a UL tested CMC ATOM Global Harness (California Mountain Corporation, Santa Barbara, CA) meeting ANSI Z359.11-2014 and NFPA 1983-2017 standards, if they don't have their own. The person will be secured with double Vs from the litter sides to the harness and footloops supporting them so their weight is on their feet and only minimally on the harness (if vertical). This process is consistent with industry standards for securing a patient in the litter and follows the specific model of the National Cave Rescue Commission.3 See figure 1 Prior to being secured in the litter the patient will do sitting baseline FEV1 and FVC with an NDDD spirograph. Once there is baseline data the subject will be secured in the litter. The investigators will then repeat spirometry, pulse, and blood pressure in a horizontal position (see figure 2), in a vertical position (see figure 3), and pitched slightly forward in a position that results from a Pike and Pivot rigging for raising up past a difficult cliff edge (see figure 4). The subject will get a rest period in their preferred position until pulse returns to within 5 beats of baseline.
Litter suspension will be with a four-legged litter spider when horizontal, with a high bridle tied directly to the litter head for the full vertical position, and from a low bridle in Pike-and-Pivot formation when pitched forward. The litter will be lifted into position with a 3:1 mechanical advantage system tied to an anchor. No matter the position, the lowest point of the litter will be no more than 6 inches off of the ground. The system will be configured for immediate lower for any expressed concern. The PI (RM) is a technical rescue instructor for the National Cave Rescue Commission and Assistant Training Officer-Technical Rescue for Fresno County search and rescue. The Co-PIs (SS and SD) are on the rope team of Fresno County search and rescue. Each is well versed in rope systems, anchor selection, and patient packaging.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
California
-
Fresno, California, Estados Unidos, 93701
- UCSF Fresno
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion Criteria:
- 130-310 pounds
Exclusion Criteria:
- Significant cardiac or pulmonary diseae
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: Randomizado
- Modelo Intervencional: Atribuição sequencial
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Comparador Ativo: Flat
Secured in a flat litter |
Testing basic pulmonary function in three positions in a rescue litter, compared to sitting baseline |
|
Comparador Ativo: Vertical
Secured in a vertical litter |
Testing basic pulmonary function in three positions in a rescue litter, compared to sitting baseline |
|
Comparador Ativo: Pitched forward
Secured in a litter leaning forward |
Testing basic pulmonary function in three positions in a rescue litter, compared to sitting baseline |
|
Comparador de Placebo: Baseline
Sitting baseline pulmonary function |
Testing basic pulmonary function in three positions in a rescue litter, compared to sitting baseline |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Forced Vital Capacity
Prazo: Immediately
|
Measurable lung volume on expiration |
Immediately
|
Outras medidas de resultado
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
FEV1
Prazo: Immediately
|
Air volume exhaled in 1 second |
Immediately
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Roger B Mortimer, MD, UCSF - Fresno
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Palavras-chave
Outros números de identificação do estudo
- 25-45106
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
Deidentified data will be submitted to a statistician
Prazo de Compartilhamento de IPD
1/1/26 to 6/1/26
Critérios de acesso de compartilhamento IPD
Roger Mortimer, MD Sarah Davis, DO Sue Spano, MD Amanda Mortimer, PhD
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .